StockData
BioMarin Pharmaceutical Inc logo

BioMarin Pharmaceutical Inc (BMRN) stock

BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3093% above fair value
$58.51+0.52 (+0.90%)

Close on Nov 17, 2026Market cap $11.33BP/E 154.0Yield –

BioMarin Pharmaceutical EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

BioMarin Pharmaceutical's EV/EBITDA was 48.3× on Nov 11, 2026, against 13.3× a year earlier. Over the last 5 years it ranged from 10.3× to 542.7×, with a median of 49.4×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202648.3×+34.1
2025Dec 31, 202514.2×−11.5
2024Dec 31, 202425.8×−43.0
2023Dec 29, 202368.8×−16.0
2022Dec 30, 202284.9×−280.5
2021Dec 31, 2021365.4×+224.8
2020Dec 31, 2020140.6×−81.1
2019Jan 31, 2019221.6×+32.0
2018Dec 31, 2018189.6×−17.2
2012Jan 31, 2012206.8×+7.7
2011Dec 30, 2011199.0×+130.1
2010Dec 31, 201068.9×+38.8
2009Dec 31, 200930.1×–

More BioMarin Pharmaceutical figures

See a number that looks wrong?